|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14 Pt 1
|
|
pubmed:dateCreated |
2006-7-21
|
|
pubmed:abstractText |
Many of the patients with extrahepatic bile duct carcinoma (EHBDC) show a poor outcome. We have reported that MUC4 is a novel prognostic factor of pancreatic adenocarcinoma and intrahepatic cholangiocarcinoma. The aim of this study is to evaluate the prognostic significance of MUC4 expression in EHBDC.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4257-64
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:16857800-Adult,
pubmed-meshheading:16857800-Aged,
pubmed-meshheading:16857800-Aged, 80 and over,
pubmed-meshheading:16857800-Bile Duct Neoplasms,
pubmed-meshheading:16857800-Bile Ducts, Extrahepatic,
pubmed-meshheading:16857800-Carcinoma,
pubmed-meshheading:16857800-Female,
pubmed-meshheading:16857800-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16857800-Humans,
pubmed-meshheading:16857800-Immunohistochemistry,
pubmed-meshheading:16857800-Male,
pubmed-meshheading:16857800-Middle Aged,
pubmed-meshheading:16857800-Mucin-4,
pubmed-meshheading:16857800-Mucins,
pubmed-meshheading:16857800-Neoplasm Metastasis,
pubmed-meshheading:16857800-Prognosis,
pubmed-meshheading:16857800-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
|
|
pubmed:affiliation |
Department of Human Pathology, Field of Oncology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
